spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase

AirBridgeCargo Airlines


AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase AirBridgeCargo Airlines (ABC), one of the leaders in transportation of pharmaceutical products by air, and Zurich-based cold-chain ULD manufacturer SkyCell have sealed their partnership for the lease of all types of SkyCell containers to meet the demand for evolving volumes of passive pharmaceutical shipments, which reached around 3,500 tonnes for 1Q 2019 YOY and demonstrated a two-fold increase.

The SkyCell line of passive containers is capable of keeping the internal temperature within the range of +2° to +8°C and +15°C to +25°C under external temperature excursions from –35°C to +65°C to meet the requirements of various pharmaceutical manufacturers, as well as logistics companies involved in a complex transportation process.

“With SkyCell containers we have increased the total number of cold-chain special packaging solutions partners till three, aiming at embracing all leading manufacturers to cater to the needs of different customers. SkyCell data-collection enablement supports our intention to move further with ‘Internet of Things’ penetration into the industry and step aside from peer-to-peer data sharing to information transparency and availability. On top of this, it fosters an extra piece of mind for our customers to have real-time data in one click,” – stated Fedor Novikov, Deputy General Director, Products, AirBridgeCargo Airlines.

“ABC has one of the most modern airline fleets and, like SkyCell, is committed to greater transparency in the industry. Together we strive to make pharmaceutical logistics safer, more reliable and more sustainable.” said Richard Ettl, CEO of SkyCell.

AirBridgeCargo has adapted a thorough and well-balanced approach towards development of its dedicated ‘abc pharma’ product, reinforcing its team of experts, expanding its pool of special packaging manufacturers, adopting the latest digital solutions, but most importantly, deepening its field-specific knowledge and sharing it with customers and partners through educational workshops and aircraft tours.

About AirBridgeCargo Airlines

AirBridgeCargo is one of the global cargo carriers with an expanded international route network which connects customers in the largest trans-regional markets of Asia, Europe, and North America and covers more than 30 major cargo gateways, accommodating trade flows worldwide. All the flights are operated via ABC’s cargo hub in Moscow Sheremetyevo airport, featuring up-to-date equipment and guaranteeing seamless connection throughout the airline’s expanded international network within a 48-hour delivery time, including handling, all managed by highly skilled and qualified ground handling personnel. ABC’s fleet consists of 18 Boeing 747 freighters and is one of the youngest and most modern in the airline industry.
More information – www.airbridgecargo.com

About SkyCell

SkyCell is a leading airfreight container provider with the mission to supply the safest pharma containers worldwide. This is achieved through the unique combination of hardware, software and service, enabling our clients to master logistical challenges and eliminate temperature excursion. Pharma companies have tested and verified SkyCell as the safest solution on the market, with less than 0.1% temperature deviations since launch. The efficient insulation and cutting-edge cooling technology enable the containers to keep the temperature for 160h+. All containers are equipped with IoT sensors, leading to a seamless supply chain through global tracking and monitoring. Based in Switzerland and with a global service station network, SkyCell is serving pharma companies around the world. For more information visit www.skycell.ch
phone + 7 495 7862613
email info@airbridgecargo.com
web www.airbridgecargo.com
email Building 16/1, Malaya Pirogovskaya, Moscow 119435
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms

Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >>


White Papers

Cleaning Validation: What do you need to consider to ensure a successful outcome?

RSSL

Cross contamination must be avoided in the Pharmaceutical industry at all costs and successful cleaning validation ensures that patients are not put at risk due to cross contamination. The process can be divided into a number of sections each of which must be fully understood and areas of concern addressed to ensure a successful outcome across the entire process. This spans both the manufacturing and subsequent analytical and microbological support. The data used to confirm a positive/successful cleaning validation is underpinned by the results of validated analytical methods. It is essential that these results are truly representative as patient safety is based upon the absence of equipment residues. So what are those areas of concern, what affects your ability to get a successful outcome and what do you need to consider when carrying out a Cleaning Validation exercise?
More info >>

Industry Events

ELRIG Drug Discovery 2019 – Looking Back to the Future

5-6 November 2019, ACC, Liverpool

Now in its 13th year, ELRIG’s flagship conference Drug Discovery 2019 will take place at ACC in Liverpool. This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery. Our scientific programme will feature over 40 world-class speakers with 6 main session tracks. In partnership with key academic and charitable groups, we will also run joint disease and biology-oriented tracks focusing on the basic sciences that underpin successful drug discovery.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement